NO952688D0 - N-acyl-pyrrolidiner og medikamenter for behandling eller prevensjon av cholecystokinin- og eller gastrin-relaterte tilstander - Google Patents
N-acyl-pyrrolidiner og medikamenter for behandling eller prevensjon av cholecystokinin- og eller gastrin-relaterte tilstanderInfo
- Publication number
- NO952688D0 NO952688D0 NO952688A NO952688A NO952688D0 NO 952688 D0 NO952688 D0 NO 952688D0 NO 952688 A NO952688 A NO 952688A NO 952688 A NO952688 A NO 952688A NO 952688 D0 NO952688 D0 NO 952688D0
- Authority
- NO
- Norway
- Prior art keywords
- cholecystokinin
- gastrin
- drugs
- prevention
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9300078A FR2700166B1 (fr) | 1993-01-07 | 1993-01-07 | Dérivés de pyrrolidine, leur préparation et les médicaments les contenant. |
| PCT/FR1994/000009 WO1994015915A1 (fr) | 1993-01-07 | 1994-01-03 | N-acyl pyrrolidines et des medicaments pour le traitement ou la prevention des desordres lies a la ckk et la gastrine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO952688D0 true NO952688D0 (no) | 1995-07-06 |
| NO952688L NO952688L (no) | 1995-08-29 |
Family
ID=9442867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO952688A NO952688L (no) | 1993-01-07 | 1995-07-06 | N-acyl-pyrrolidiner og medikamenter for behandling eller prevensjon av cholecystokinin- og eller gastrin-relaterte tilstander |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5707991A (no) |
| EP (1) | EP0678089B1 (no) |
| JP (1) | JPH08505849A (no) |
| KR (1) | KR960700229A (no) |
| AT (1) | ATE143947T1 (no) |
| AU (1) | AU5819394A (no) |
| CA (1) | CA2152185A1 (no) |
| DE (1) | DE69400704T2 (no) |
| DK (1) | DK0678089T3 (no) |
| ES (1) | ES2094638T3 (no) |
| FR (1) | FR2700166B1 (no) |
| GR (1) | GR3021314T3 (no) |
| HU (1) | HUT74094A (no) |
| IL (1) | IL108288A0 (no) |
| NO (1) | NO952688L (no) |
| NZ (1) | NZ259399A (no) |
| WO (1) | WO1994015915A1 (no) |
| ZA (1) | ZA9429B (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2721608B1 (fr) * | 1994-06-22 | 1996-07-19 | Rhone Poulenc Rorer Sa | Dérivés de thiazolidine, leur préparation et les médicaments les contenant. |
| FR2734724B1 (fr) * | 1995-06-01 | 1997-07-04 | Rhone Poulenc Rorer Sa | Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'alcoolisme |
| FR2744362B1 (fr) * | 1996-02-07 | 1998-02-27 | Rhone Poulenc Rorer Sa | Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif |
| TW533196B (en) * | 1998-09-23 | 2003-05-21 | Merck & Co Inc | Improved stereoselective process for ENALAPRIL |
| ITRM20020014A1 (it) * | 2002-01-15 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del |
| DE60334016D1 (de) | 2002-11-05 | 2010-10-14 | Glaxo Group Ltd | Antibakterielle mittel |
| AU2006332945C1 (en) * | 2005-12-23 | 2013-02-28 | Wyeth | Modified lysine-mimetic compounds |
| EP2074087A2 (en) * | 2006-12-21 | 2009-07-01 | Wyeth | Synthesis of pyrrolidine compounds |
| DK3618847T3 (da) | 2017-05-05 | 2021-05-25 | Boston Medical Ct Corp | GAP-junction-modulatorer af intercellulær kommunikation og deres anvendelse til behandling af diabetisk øjensygdom |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0124317B1 (en) * | 1983-04-27 | 1990-04-11 | Ici Americas Inc. | Proline derivatives |
| FR2667864B2 (fr) * | 1990-03-07 | 1994-08-05 | Rhone Poulenc Sante | Derives de n-phenyl glycinamides, leur preparation et les medicaments les contenant. |
| FR2678938B1 (fr) * | 1991-07-10 | 1993-10-08 | Rhone Poulenc Rorer Sa | Derives de pyrrolidine, leur preparation et les medicaments les contenant. |
-
1993
- 1993-01-07 FR FR9300078A patent/FR2700166B1/fr not_active Expired - Fee Related
-
1994
- 1994-01-03 DE DE69400704T patent/DE69400704T2/de not_active Expired - Fee Related
- 1994-01-03 KR KR1019950702824A patent/KR960700229A/ko not_active Application Discontinuation
- 1994-01-03 AT AT94903940T patent/ATE143947T1/de not_active IP Right Cessation
- 1994-01-03 NZ NZ259399A patent/NZ259399A/en unknown
- 1994-01-03 ES ES94903940T patent/ES2094638T3/es not_active Expired - Lifetime
- 1994-01-03 DK DK94903940.8T patent/DK0678089T3/da active
- 1994-01-03 JP JP6515748A patent/JPH08505849A/ja active Pending
- 1994-01-03 CA CA002152185A patent/CA2152185A1/fr not_active Abandoned
- 1994-01-03 WO PCT/FR1994/000009 patent/WO1994015915A1/fr active IP Right Grant
- 1994-01-03 EP EP94903940A patent/EP0678089B1/fr not_active Expired - Lifetime
- 1994-01-03 AU AU58193/94A patent/AU5819394A/en not_active Abandoned
- 1994-01-03 US US08/448,401 patent/US5707991A/en not_active Expired - Fee Related
- 1994-01-03 HU HU9502068A patent/HUT74094A/hu unknown
- 1994-01-04 ZA ZA9429A patent/ZA9429B/xx unknown
- 1994-01-06 IL IL10828894A patent/IL108288A0/xx unknown
-
1995
- 1995-07-06 NO NO952688A patent/NO952688L/no unknown
-
1996
- 1996-10-10 GR GR960401907T patent/GR3021314T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2700166B1 (fr) | 1995-02-17 |
| DE69400704T2 (de) | 1997-03-13 |
| EP0678089A1 (fr) | 1995-10-25 |
| EP0678089B1 (fr) | 1996-10-09 |
| NZ259399A (en) | 1996-07-26 |
| WO1994015915A1 (fr) | 1994-07-21 |
| ES2094638T3 (es) | 1997-01-16 |
| AU5819394A (en) | 1994-08-15 |
| DK0678089T3 (da) | 1996-11-18 |
| KR960700229A (ko) | 1996-01-19 |
| DE69400704D1 (de) | 1996-11-14 |
| IL108288A0 (en) | 1994-04-12 |
| HUT74094A (en) | 1996-11-28 |
| HU9502068D0 (en) | 1995-09-28 |
| CA2152185A1 (fr) | 1994-07-21 |
| ATE143947T1 (de) | 1996-10-15 |
| GR3021314T3 (en) | 1997-01-31 |
| JPH08505849A (ja) | 1996-06-25 |
| US5707991A (en) | 1998-01-13 |
| FR2700166A1 (fr) | 1994-07-08 |
| ZA9429B (en) | 1994-08-11 |
| NO952688L (no) | 1995-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2150489T3 (es) | 1-amidinofenil-pirrolidonas, -piperidinonas, -azetinonas como inhibidores de la agregacion de plaquetas. | |
| DZ1794A1 (fr) | Nouvelle formule pharmaceutique. | |
| IL108520A0 (en) | Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them | |
| FI964772A0 (fi) | (a)-annelloidut pyrrolijohdannaiset ja niiden käyttö farmasiassa | |
| FI972434A0 (fi) | Lamotrigiiniä sisältävä farmaseuttinen koostumus | |
| NO952688L (no) | N-acyl-pyrrolidiner og medikamenter for behandling eller prevensjon av cholecystokinin- og eller gastrin-relaterte tilstander | |
| DE59509537D1 (de) | Pyrimidin- oder triazincarbonsäurederivate zur verwendung als arzneimittel | |
| FI964482A (fi) | Amidijohdannaisia ja niiden käyttö lääkkeenä | |
| HU9502067D0 (en) | N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders | |
| NO950177L (no) | Farmakologisk aktive erivater |